ArticleCureus2022

Increasing Patient Safety Among Multiple Sclerosis (MS) Drug Dalfampridine Users by Expanding Awareness of the Serious Side Effects.

Rameez Zaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.